tradingkey.logo

Myomo Inc

MYO
查看詳細走勢圖
0.803USD
+0.030+3.88%
收盤 02/06, 16:00美東報價延遲15分鐘
30.87M總市值
虧損本益比TTM

Myomo Inc

0.803
+0.030+3.88%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.88%

5天

-4.29%

1月

-18.07%

6月

-56.11%

今年開始到現在

-11.75%

1年

-86.79%

查看詳細走勢圖

TradingKey Myomo Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Myomo Inc當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名85/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為5.00。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Myomo Inc評分

相關信息

行業排名
85 / 205
全市場排名
233 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Myomo Inc亮點

亮點風險
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
業績高增長
公司營業收入穩步增長,連續3年增長109.26%
業績增長期
公司處於發展階段,最新年度總收入32.55M美元
估值高估
公司最新PE估值-2.80,處於3年歷史高位
機構減倉
最新機構持股21.70M股,環比減少16.85%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉1.56M股
活躍度增加
近期活躍度增加,過去20天平均換手率2.52

分析師目標

基於 5 分析師
買入
評級
5.000
目標均價
+522.59%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Myomo Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Myomo Inc簡介

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
公司代碼MYO
公司Myomo Inc
CEOGudonis (Paul R)
網址https://myomo.com/
KeyAI